Pembrolizumab and Lenvatinib After Definitive Chemoradiation of Locally Advanced HNSCC
Clinical trial NCT05433116 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05433116
- Sponsor
- Universität des Saarlandes
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-25
- Primary completion
- 2026-01-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.